Lars Ekman is Director at PROTHENA CORP PUBLIC LTD CO (PRTA). They have made 15 open-market trades across 3 companies since 2013, most recently 2023-01-03.
CIK 0001376117
1 open-market purchase totalling $72K since 2013, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRTA | SELL | 2023-01-03 | 2023-01-05 | $55.97 | $1.8M | +3.9% | +10.5% | -8.5% |
| PRTA | SELL | 2022-12-01 | 2022-12-02 | $61.60 | $2.0M | -10.7% | -17.6% | -18.4% |
| PRTA | SELL | 2022-11-01 | 2022-11-03 | $62.89 | $2.0M | +14.7% | +11.4% | -1.0% |
| PRTA | SELL | 2022-10-03 | 2022-10-05 | $61.52 | $1.9M | +0.6% | -5.5% | -7.3% |
| PRTA | SELL | 2022-09-28 | 2022-09-30 | $48.09 | $3.0M | -14.0% | +0.9% | -2.0% |
| AMRN | SELL | 2019-11-12 | 2019-11-13 | $19.35 | $747K | -1.9% | +12.2% | -16.7% |
| AMRN | SELL | 2019-11-05 | 2019-11-07 | $18.00 | $115K | +36.1% | +35.1% | +12.1% |
| AMRN | SELL | 2019-09-03 | 2019-09-05 | $15.01 | $2.7M | +7.4% | -8.7% | +42.6% |
| AMRN | SELL | 2019-03-04 | 2019-03-06 | $21.25 | $5.0M | -9.7% | -7.6% | -16.6% |
| AMRN | SELL | 2019-03-04 | 2019-03-06 | $21.31 | $2.9M | -9.7% | -7.6% | -16.6% |
| AMRN | SELL | 2019-01-10 | 2019-01-11 | $17.47 | $4.5M | +2.7% | -2.1% | +8.8% |
| AMRN | SELL | 2019-01-10 | 2019-01-11 | $17.28 | $2.4M | +2.7% | -2.1% | +8.8% |
| PRTA | SELL | 2015-11-25 | 2015-11-25 | $73.35 | $2.2M | -31.1% | -7.0% | -51.0% |
| SPHS | SELL | 2014-12-18 | 2015-01-23 | $0.47 | $5K | N/A | N/A | N/A |
| AMRN | BUY | 2013-11-20 | 2013-11-20 | $1.80 | $72K | -18.3% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.